US FDA, USP Cooperate On Small Molecule Drug Monograph Updates To Speed ANDAs

 
• By Derrick Gingery
  
Generics
Using the USP Pending Monograph Process could help generics reach the market faster, US FDA says. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Generics

More from Biosimilars & Generics